Syndivia lands €275k grant to develop next-generation targeted cancer therapies

Written By Syndivia

Syndivia was nominated laureate of the i-LAB 2015 in the category "création-développement". i-LAB is a nationwide contest of innovative companies supported by the French Ministry of Higher Education and Research. The prize includes €275k financial support for Syndivia's R&D program on the development of next-generation targeted cancer therapies.

9838246.png
Syndivia https://syndivia.com
Previous

Publication in Bioconjugate Chemistry
Next

Syndivia is among the TOP 100 SMEs of the Hello Tomorrow Challenge